The surface expression of PECAM-1, an inhibitory adhesion receptor that is cleaved from the leukocyte surface in inflammatory conditions [12,13], was not significantly changed in patients with COVID-19 (Figure 2E). Here, PECAM1 is linked to COVID-19.